HOSPITALITY
Fortis Healthcare Plans To Provide Healthcare Services In Ashok Vihar
Fortis Healthcare Ltd has signed a definitive agreement with Seth Sunder Lal Jain Charitable Eye Hospital to provide healthcare services at a planned 400-bed super specialty hospital in Ashok Vihar, New Delhi. The hospital is expected to commence operations in three to four years, subject to necessary approvals. The agreements have been executed by Fortis […]
CW Bureau
·
Sep 16, 2026
GENERAL
Kwality Pharma Ups FY27 Guidance, Targets ₹1,000 Cr Revenue By FY29
Kwality Pharmaceutical Ltd, which has doubled its turnover to ₹500 crore in three years, has raised its FY27 revenue guidance to over ₹700 crore from ₹650 crore and is targeting more than ₹1,000 crore by FY29. “Over the longer term, we continue to work toward doubling revenue over the next three years, with a goal […]
CW Bureau
·
Aug 10, 2026
GENERAL
Narayana Health Bets On Paid Clinics, Digital Care For Next Growth Phase
Narayana Hrudayalaya Ltd plans to expand its neighbourhood clinic network, scale digital healthcare and strengthen its oncology platform as part of its long-term growth strategy. The company is also expanding its global healthcare footprint while investing in affordable and technology-driven healthcare solutions. Subscription-based care “Primary care in India remains largely unorganised and disjointed. To bridge […]
CW Bureau
·
Jul 24, 2026
GENERAL
Glenmark Specialty Advances Global Phase 3 Trial For Ovarian Cancer Drug
Glenmark Pharmaceuticals Ltd, through its wholly owned subsidiary Glenmark Specialty S.A., has advanced the Phase 3 clinical development of Trastuzumab rezetecan, a HER2-targeted antibody-drug conjugate (ADC), for the treatment of platinum-resistant ovarian cancer (PROC). India will become the first country across Glenmark’s licensed markets to initiate patient enrolment for the global Phase 3 clinical trial […]
CW Bureau
·
Jul 2, 2026
GENERAL
Shilpa Biologicals Commissions ADC Drug Substance Manufacturing Unit
Shilpa Biologicals Ltd, a material subsidiary of Shilpa Medicare Ltd, has commissioned a Good Manufacturing Practice (GMP)-compliant Antibody-Drug Conjugate (ADC) manufacturing facility designed to meet global regulatory standards. The facility is fully operational, with GMP qualification protocols currently underway, paving the way for commercial-scale operations. Integrated ADC capabilities With the commissioning of the facility, Shilpa […]
CW Bureau
·
Jun 24, 2026
GENERAL
Cipla Bets On Innovation, Biosimilars And AI To Drive Next Phase Of Growth
Cipla Ltd, the Mumbai-headquartered global pharmaceutical major, is stepping up investments in innovation, artificial intelligence, biosimilars and strategic acquisitions as it looks to strengthen its position across key global markets and build a future-ready organisation. India will remain a key growth driver, with the company focusing on therapy areas including respiratory, cardiology, diabetology, urology, oncology, […]
CW Bureau
·
Jun 2, 2026
HOSPITALITY
Park Group Launches Panchkula Hospital, Expands Mohali Unit
Park Group Launches Panchkula Hospital, Expands Mohali Facility to Build 850-Bed Tricity Healthcare Network Park Group of Hospitals has approved the launch of an advanced multi-super specialty hospital in Panchkula, with a capacity expandable to 350 beds, along with a 150-bed expansion of its existing 350-bed facility in Mohali. The expansion strengthens the group’s footprint […]
CW Bureau
·
Mar 10, 2026
HOSPITALITY
Narayana Hrudayalaya Eyes Deeper Presence In Bengaluru And Kolkata
Narayana Hrudayalaya Ltd is recalibrating its growth strategy to strengthen its presence in core markets such as Bengaluru and Kolkata, moving away from an earlier bed-driven expansion model, Vice Chairman Viren Shetty said during an earnings call. Articulating the group’s long-term vision, Shetty said the company remains committed to building a world-class healthcare institution that […]
CW Bureau
·
Feb 25, 2026
